Upstream Bio UPB
NASDAQ UPB
$5.30 +0.11 (+2.02%)
As of: Sep 30, 2026 · 3:18 PM EDT

Upstream Bio (UPB) Market Capitalization (2024 - 2026)

Updated

Upstream Bio (UPB) recorded Market Capitalization of $379.02 million in Q2 2026, down 35.8% from $590.7 million a year earlier and down 22.6% from the prior quarter.

Analysis

Upstream Bio (UPB) Market Capitalization (2024 - 2026) Analysis & Trends

For FY2025, Upstream Bio reported Market Capitalization of $1.47 billion, up 554.7% from FY2024.

  • Across earlier years, Market Capitalization came in at $224.94 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly Market Capitalization since Q1 2025.
  • Per Business Quant, the preceding three quarters came in at $489.78 million (Q1 2026), $1.47 billion (Q4 2025) and $1.02 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Upstream Bio 284.26 Mn 284.26 Mn -3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 379.02 Mn
Mar 31, 2026 489.78 Mn
Dec 31, 2025 1.47 Bn
Sep 30, 2025 1.02 Bn
Jun 30, 2025 590.70 Mn
Mar 31, 2025 328.28 Mn
Dec 31, 2024 224.94 Mn
API Access

Upstream Bio Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=UPB&period=max&api_key=YOUR_API_KEY